During the 2014-2020 period, the Bio-based Industries Joint Undertaking (BBI JU) has funded 142 projects, involving 1,055 beneficiaries in 39 countries. BBI JU projects contribute to a sustainable and competitive bioeconomy in Europe by bringing together various stakeholders, stimulating investments, structuring and mobilising the bio-based industry sector, boosting market uptake and supporting innovation.
Involving stakeholders from across Europe
BBI JU projects mobilise all relevant stakeholders – SMEs, large industries, clusters, primary producers, trade associations, academia, research centres, and end-users – to develop technologies and business models advancing Europe’s green economy. Funding to the BBI JU beneficiaries is well-balanced across main actors:
SMEs receive 37% of the BBI JU funding. They represent 40% of all beneficiaries and two-thirds of the private organisations taking part in the projects. With the help of BBI JU’s funding, small businesses scale up their technologies and get access to the market. At the same time, as technology and innovation providers, they play a key role in the projects.
Universities and research centres receive 30% of all BBI JU funding and represent 25% of all participations in projects. Their collaboration with industry and other bioeconomy actors in the projects helps bring crucial innovations closer to the market.
BBI JU’s project participants are active across Europe. For example, the flagship biorefineries are set in Estonia, France, Ireland, Italy, Latvia, the Netherlands, Norway, Romania and Spain. They represent a great variety of business models transforming a wide range of sustainable feedstock sourced locally
By pulling together both public and private funds, the BBI JU attracts financing from the industry sector to multiply Horizon 2020 budget resources. For the period from 2014 until the end of the initiative in 2024, the contribution by the Bio-based Industries Consortium (BIC) and/or its constituent entities will be at least €2.73 billion and the EU contribution up to €975 million. This means that by 2024 each euro of public funding will have generated a minimum of € 2.8 in private contributions.
In this way, the BBI JU helps mobilise investments to benefit SMEs, universities, research centres, and academia dedicated to R&I activities relevant to the bio-based sector.
Structuring and mobilising the bio-based industries
The two main positive impacts of BBI JU are the structuring effect in organising the value chains across sectors and the innovation-driven mobilising effect of key stakeholders. BBI JU projects result in innovative interconnected bio-based value chains and new cross-sectoral collaborations, which are fundamental to make the European economy abreast of the times.
The outcomes of BBI JU projects include:
- More than 230 new bio-based value chains expected by 2024 versus the SIRA target of 10 new ones
- More than 270 new cross-sector interconnections expected by 2024 versus the SIRA target of 36 new ones
Boosting market uptake
BBI JU is helping to bring innovations to the market by supporting the creation and boosting large-scale production of sustainable products and materials with an equal or overall better performance than their fossil-based counterparts. This results in a wide range of innovations aimed at satisfying consumer and industrial needs.
The outcomes of BBI JU projects include:
- Over 230 new bio-based materials expected by 2024 versus the SIRA target of 50 new ones
- Over 120 new bio-based chemical building blocks expected by 2024 versus the SIRA target of 5 new ones
- More than 150 new bio-based products expected by 2024 versus the SIRA target of 30 new ones
Creating science and knowledge
BBI JU enables scientific advancements, as well as knowledge creation and sharing in the bio-based sector. All our projects work to increase maturity levels in technologies, making the leap from lab-scale testing to industrial-scale biorefineries.
At least 55 technological advancements for core technologies are expected by 2024 versus the SIRA target of 20 new advancements.